Drug Discovery Product Showcase

  1. High Performance, Reliable, And Flexible Bioreactors 7/17/2023

    High performance, reliability, and flexibility define this next-generation single-use system.

  2. CHO Platform Service Package For Biopharmaceutical Cell Line Development 6/28/2023

    Learn how this CHO platform service package can help you rapidly progress from DNA to GMP cell bank (MCB | WCB) and overcome typical obstacles that can delay a first commercial manufacturing batch.

  3. Protein L Resin For Affinity Capture 5/3/2023

    MabSelect™ VL resin — protein L resin for affinity capture of antibody Fabs, bispecifics, and other variants containing a kappa light chain.

  4. Resin Offering High Productivity And Robust Processes 5/3/2023

    MabSelect™ VL affinity resin uses a protein L ligand with strong affinity for the variable region of a human antibody’s kappa light chain. The resin offers high productivity and robust processes for affinity capture of bispecific antibodies and antibody fragments containing the kappa light chain and offers a good capture alternative for antibody variants that does not bind to protein A.

  5. Bionanoparticle Technology 4/24/2023

    Nanoform’s proprietary bionanoparticle technology can deliver large-molecule drug particles as small as 50 nm while retaining biological activity. This can not only enable more patient-friendly approaches to drug delivery, but also potentially higher loads of active ingredients.

  6. GMP Manufacturing 4/24/2023

    Nanoform’s GMP facility utilizes its award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology for the manufacture of API nanoparticles to GMP standards.

  7. Pharmaceutical Development 4/24/2023

    Developing an optimized formulation tailored to your API nanoparticles is critical to unlocking their full potential.

  8. Controlled Expansion Of Supercritical Solutions (CESS®) Technology 4/24/2023

    Nanoform’s award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology is a bottom-up nanoparticle engineering approach that enables the creation of API nanoparticles and can unlock the full therapeutic potential of small molecule drugs.

  9. Biopharma Manufacturing Solutions 4/13/2023

    Address biomanufacturing capacity with flexibility, speed and confidence.

  10. Access cGMP Biomanufacturing Capacity Faster 4/11/2023

    Discover a software solution that enables the rapid, pretested, and pre-verified integration of your bioproduction equipment into a central data storage, visualization, and reporting infrastructure.